OVERCOMING IMMUNOTHERAPY RESISTANCE IN CANCER: MOLECULAR MECHANISMS, PREDICTIVE BIOMARKERS, AND EMERGING THERAPEUTIC STRATEGIES . FMHR 2026, 4 (2), 56-73.